Telix strikes deal to distribute cancer imaging agent in the Nordics – Pharmaceutical Technology
Prostate cancer was a a leading cause of cancer death in men, with almost 6,000 men dying from the disease in the Nordic region in
Prostate cancer was a a leading cause of cancer death in men, with almost 6,000 men dying from the disease in the Nordic region in
The panel discussion at the 11th Annual Outsourcing in Clinical Trials Nordics, saw representitives from Camurus, Zealand Pharma and Leo Pharma. Credit: Shutterstock / Gorodenkoff
Traditionally oncology patients have not been compensated for participating in clinical trials. Credit: Shutterstock / Kunlanan Yarist Sponsors are being urged to compensate participants in
At present Voxzogo is currently marketed in the European Union in children with achondroplasia who are 2 years of age and older with open growth
The multi-center, Phase IIa, dose-escalation clinical trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus. Credit Shutterstock /
SAGE-718 is currently undergoing two other clinical trials, including into its use in patients with Alzheimer’s and Parkinson’s diseases. credit: Shutterstock / Yanawut.S Sage Therapeutics’
The company has said that its novel drug SEFA-6179 was well tolerated in Phase I trials. Credit: Shutterstock / Studio Romantic Dutch biotech firm, NorthSea
Illumina has been ordered to divest itself of GRAIL after the European Commission feared it would limit customer choice. Credit: Shutterstock / Vitalii Vodolazskyi Illumina
The researchers at Birmingham’s the Institute of Cardiovascular Sciences have been able to make platelets clump together in a predictable way. Credit: Shutterstock / Marso
Microbiome mapping technology company Kanvas Biosciences has announced the acquisition of assets from California-based Federation Bio, bringing with it two active therapeutics programmes. Kanvas Biosciences